methylene blue/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases hospital length of stay
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Findingreplicated ×1“Consequently, the mean length of hospital stay was significantly shorter for patients receiving MBI (3.80 ± 0.85 days) than for controls (5.43 ± 1.01 days; P <.001).”
Quoted verbatim from The effect of methylene blue infiltrating injection on anal pain after Milligan-Morgan surgery: A randomized controlled clinical study.. - Study
- RCT
- Participants
- 60
- Dose
- single intraoperative subcutaneous infiltration of 0.5-1 mL of 0.1% methylene blue per incision site, total not exceeding 5 mL
- Population
- adults with mixed haemorrhoids after Milligan-Morgan haemorrhoidectomy; secondary endpoint; reported in days; both arms received the same on-demand intravenous lornoxicam protocol
The effect of methylene blue infiltrating injection on anal pain after Milligan-Morgan surgery: A randomized controlled clinical study.2026PMID:41686620Permalink
Keep reading
- Everything the graph holds on methylene blue
- Every compound studied against Hospital length of stay
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M1099KW8Z7904PW2BJGS7777